Skip to main content

Euphorbiaceae Family Oriented Drug Discovery

Exploration of Isolation, Identification, Total Synthesis, and Drug Discovery Based on Natural Products from Euphorbiaceae Family

  • 1st Edition - January 1, 2027
  • Latest edition
  • Authors: Bingjie Li, Linlin Shi
  • Language: English

Euphorbiaceae Family Oriented Drug Discovery, a volume in the Drug Discovery Opinions series, aims to comprehensively explore the isolation, identification, synthesis, and drug d… Read more

Description

Euphorbiaceae Family Oriented Drug Discovery, a volume in the Drug Discovery Opinions series, aims to comprehensively explore the isolation, identification, synthesis, and drug discovery based on natural products derived from the Euphorbiaceae family. The goals for this editorial project are to consolidate the existing knowledge in this field, fill the gaps in research, and foster further advancements in pharmaceutical science and medicine. The rich diversity and potential pharmacological activities of natural products from this botanic family serves as a springboard for this complete reference. Focused on the isolation, identification, synthesis of bioactive compounds, and drug discovery techniques, the contents of the book are organized into ten chapters. The book opens with an introduction to the Euphorbiaceae family, its botanical overview, medicinal significance, and the importance of exploring its natural products for drug discovery. The next chapters focuses on specific techniques for identification, and synthesis of natural products. Chapter four covers the antitumor activities and mechanisms of action of natural products, followed by a chapter on the specific antimicrobial properties and mechanisms of action. Chapter six discusses anti-inflammatory properties, while chapter seven focuses on pharmacology. Chapter eight is focused on drug discovery processes for Euphorbiaceae Natural Products. The next chapter describe challenges and future directions in research. The final chapter presents the authors final considerations, summarizing the key findings and insights from the book. Euphorbiaceae Family Oriented Drug Discovery helps researchers, students, and practitioners in the fields of pharmaceutical science, pharmacology, medicine, and biotechnology, by providing a comprehensive and up-to-date resource on the natural products of the Euphorbiaceae family. The content cover the latest research findings, methodologies, and technologies used in the isolation, identification, and synthesis of these compounds, as well as their potential applications in drug discovery.

Key features

  • Provides a comprehensive overview of the entire process, from isolation and identification to synthesis and drug discovery from the Euphorbiaceae family of plants
  • Coverage of interdisciplinary areas and scientific disciplines, including botany, chemistry, pharmacology, and biotechnology
  • Offers insights into future directions and perspectives, highlighting emerging research areas and potential new leads within the Euphorbiaceae family

Readership

Academic and professional researchers focused on drug discovery and development

Table of contents

1: Botanical Overview of the Euphorbiaceae Family

2: Isolation and Identification of Natural Products from Euphorbiaceae

3: Synthesis of Natural Products from Euphorbiaceae

4: Antitumor Activities and Mechanisms of Action of Euphorbiaceae Natural Products

5: Antimicrobial Properties and Mechanisms of Action of Euphorbiaceae Natural Products

6: Anti-inflammatory Properties and Mechanisms of Action of Euphorbiaceae Natural Products

7: Pharmacological properties and Mechanisms of Action of Euphorbiaceae Natural Products

8: Drug Discovery Based on Euphorbiaceae Natural Products

9: Challenges and Future Directions in Euphorbiaceae-Based Drug Discovery

10: Conclusion

Product details

  • Edition: 1
  • Latest edition
  • Published: January 1, 2027
  • Language: English

About the authors

BL

Bingjie Li

Professor Bingjie Li is a scholar with extensive expertise in chemistry, clinical medicine, nanotechnology, and biomedical research. He completed advanced studies at renowned institutions, including the University of Oxford and Monash University, specializing in nanotechnology and palliative care, and earned a Ph.D. in Clinical Medicine from Zhengzhou University, where his research focused on inorganic chemistry and translational medicine. Professor Li has made significant contributions to nanotechnology and biomedical research, particularly through pioneering work on innovative nanomaterials for therapeutic applications in cancer and cardiovascular diseases.
Affiliations and expertise
Zhengzhou University, China

LS

Linlin Shi

Linlin Shi is a Professor of Organic Chemistry at Zhengzhou University in Henan. He received his Ph.D. degree in Organic Chemistry from Peking University in 2019 under the supervision of Prof. Zhen Yang and Prof. Jianxian Gong. In 2020, he began his independent academic career at the College of Chemistry at Zhengzhou University. He is working on the total synthesis of anticancer and antibacterial natural products and functional molecules. He has published about 60 SCI papers and co-invented 10 patents. He currently serves as editorial Board Member of Chemical Synthesis, Green Synthesis and Catalysis, Exploration, Chinese Chemical Letters, etc.
Affiliations and expertise
Zhengzhou University, China